Extramedullary blast crisis (EBC) in chronic myeloid leukemia (CML) is a rare phenomenon and represents infiltration of leukemic blasts in areas other than bone marrow. Lymph node is the most common site of involvement by EBC. We herein present a case of CML who suffered from two discrete episodes of EBC at atypical locations (scalp and paravertebral) within an interval duration of nine months. A-38-year-old female was diagnosed as a case of CML with extramedullary blast crisis in scalp at presentation. She received treatment with imatinib 600 mg once daily through Novartis Oncology Access Program (NOA). She achieved hematological remission. However nine months later she was readmitted with spinal shock due to cord compression secondary to paraspinal chloroma. She was started on tablet Nilotinib in view of failure to 1st line therapy. Her compressive myelopathy was treated with pulses of high dose dexamethasone. However soon she died due to pneumonia.
Case ReportA-38-year old lady was seen in February 2013 with complaints of scalp swelling in left parietal area of 5 9 5 cm in dimension (Fig. 1A). Rest of general physical examination was normal. Per abdomen examination revealed splenomegaly of 6 cm below left costal margin. Her total blood count showed hemoglobin-114 g/L, platelet count-417 9 10 9 /L, and total leukocyte count-146 9 10 9 /L with predominance of myeloid precursors -12 % myelocytes, 11 % metamyelocytes. Excisional biopsy of scalp swelling confirmed MPO positive chloroma (Fig. 2). Bone marrow examination showed hypercellular marrow spaces with 2 % blasts, 5 % basophils, 15 % myelocytes and 14 % metamyelocytes with mild megakaryocytic hyperplasia. BCR-ABL quantitative transcript ratio from blood was 78.35 %. Hence diagnosis of CML with extra medullary myeloid blast crisis of scalp was made. She was started on imatinib 600 mg OD. Second generation tyrosine kinase inhibitors (TKIs) or allogeneic stem cell transplantation were offered to her but she could not afford due to financial constraints. Reassessment at 3 months showed complete hematological remission with hemoglobin-113 gm/L, platelet count-135 9 10 9 /L, TLC-4.97 9 10 9 /L and no immature cells on differential count analysis. There was significant reduction in size of chloroma. Her quantitative transcript for BCR-ABL translocation was found to be 7.37 % at end of 6 months. The dose of imatinib was increased to 800 mg/day as BCR ABL transcripts levels were above 1 % at 6 months. However, 3 months later, she presented with complaints of sudden onset quadriplegia with bowel and bladder incontinence. Neurological examination revealed features suggestive of compressive myelopathy with power of 0/5 in bilateral lower limbs and pansensory loss below D4 level. An urgent CEMRI of dorsolumbar spine showed heterogeneously enhancing posterior epidural soft tissue component compressing and displacing the spinal cord at D4, 5, 6 and 7 level (Fig. 1B, C). In view of significant past history of scalp chloroma, clinical